Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 279
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00742482 | Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy | ||
| NCT03508856 | Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin | ||
| NCT04114097 | The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover | ||
| NCT00277394 | Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis | ||
| NCT01541553 | A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp | ||
| NCT04202445 | TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction | ||
| NCT04872101 | Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2) | ||
| NCT01722812 | Cromoglicate in Psoriasis | ||
| NCT00851864 | Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing | ||
| NCT03126578 | Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 and Midazolam | ||
| NCT02126371 | LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects | ||
| NCT01211964 | LEO 22811 - Single Dose Bioavailability Study of Tablet Versus Oral Solution in Healthy Subjects | ||
| NCT00392067 | LEO19123 Cream in the Treatment of Atopic Dermatitis | ||
| NCT01701843 | Cromoglicate in Mastocytosis | ||
| NCT02260414 | Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer | ||
| NCT03114618 | A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient | ||
| NCT03806790 | Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris | ||
| NCT01922050 | A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis | ||
| NCT01449513 | PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy | ||
| NCT01580488 | A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris | ||
| NCT02376049 | A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD) | ||
| NCT01963793 | Topical Aprepitant in Prurigo Patients | ||
| NCT02605057 | Dermatopharmacokinetic Trial of LEO 80185 Gel | ||
| NCT01600014 | Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp | ||
| NCT02600598 | Biological Effects of LEO 43204 in Actinic Keratosis | ||
| NCT04674826 | A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects | ||
| NCT03669757 | Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis | ||
| NCT02695940 | Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis | ||
| NCT01587755 | Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP) | ||
| NCT00403949 | A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis | ||
| NCT02594436 | The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice | ||
| NCT01422434 | LEO 90105 Ointment in Japanese Subjects With Psoriasis | ||
| NCT02219633 | Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) | ||
| NCT01555463 | Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea | ||
| NCT00845481 | A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris | ||
| NCT04306315 | Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight | ||
| NCT05388760 | Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1) | ||
| NCT03231124 | Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects. | ||
| NCT00722189 | Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses | ||
| NCT05332366 | A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia | ||
| NCT02387853 | Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis | ||
| NCT01607853 | A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis Vulgaris | ||
| NCT02602470 | Preferences & Treatment Satisfaction Drivers in Rosacea Patients | ||
| NCT02575950 | Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 in Moderate to Severe Acne | ||
| NCT01707043 | Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris | ||
| NCT00891709 | LEO 29102 Single and Multiple Dose Study by Dermal Application | ||
| NCT03514511 | Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis | ||
| NCT00640822 | Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds | ||
| NCT02748902 | Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. | ||
| NCT02038569 | An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects |
